Who owns PMV PHARMACEUTICALS INC?
- Ticker: PMVP
- CUSIP Number: 69353y103
Tip: Access positions for across all investors
Analyze quarterly positions in Pmv Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pmv Pharmaceuticals stock
Who bought or sold PMV PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 6.5M | $11M | 0% | Mar 2024 |
|
| Arrowpoint Asset Management | 3.2M | $5.4M | 18% | Mar 2024 |
|
| BlackRock | 3.1M | $5.3M | -32% | Mar 2024 |
|
| Euclidean Capital | 2.6M | $4.5M | 0% | Mar 2024 |
|
| Vanguard Group | 2.5M | $4.2M | 2% | Mar 2024 |
|
| Acadian Asset Management | 2.1M | $3.5M | 100% | Mar 2024 |
|
| Citadel Advisors | 1.6M | $2.7M | 27% | Mar 2024 |
|
| Partner Fund Management | 1.5M | $4.6M | 14% | Dec 2023 |
|
| Bank of America Corporation | 1.4M | $2.3M | -5% | Mar 2024 |
|
| BML Capital Management | 1.3M | $2.2M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 1.1M | $1.9M | 36% | Mar 2024 |
|
| Geode Capital Management | 903k | $1.5M | 12% | Mar 2024 |
|
| Jacobs Levy Equity Management | 827k | $1.4M | 92% | Mar 2024 |
|
| D. E. Shaw & Co | 721k | $1.2M | 190% | Mar 2024 |
|
| Federated Investors | 703k | $2.2M | -10% | Dec 2023 |
|
| Millennium Management | 656k | $1.1M | 100% | Mar 2024 |
|
| EcoR1 Capital | 567k | $964k | 0% | Mar 2024 |
|
| Personal Cfo Solutions | 550k | $936k | 57% | Mar 2024 |
|
| Citigroup | 523k | $889k | 0% | Mar 2024 |
|
| Barclays | 494k | $839k | -5% | Mar 2024 |
|
| Opaleye Management | 472k | $802k | 100% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 434k | $738k | 134% | Mar 2024 |
|
| Morgan Stanley | 422k | $717k | 79% | Mar 2024 |
|
| Two Sigma Investments | 400k | $680k | 43% | Mar 2024 |
|
| Two Sigma Advisers | 365k | $621k | 94% | Mar 2024 |
|
| Acuitas Investments | 352k | $598k | 100% | Mar 2024 |
|
| Northern Trust | 338k | $575k | 0% | Mar 2024 |
|
| Baker Bros. Advisors | 322k | $547k | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 273k | $464k | -51% | Mar 2024 |
|
| Charles Schwab Investment Management | 266k | $452k | 3% | Mar 2024 |
|
| M^T Bank Corporation | 259k | $439k | 31% | Mar 2024 |
|
| Point72 Asset Management | 206k | $350k | -73% | Mar 2024 |
|
| Verition Fund Management | 201k | $342k | -92% | Mar 2024 |
|
| Shay Capital | 197k | $335k | 100% | Mar 2024 |
|
| XTX Topco | 195k | $332k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 153k | $260k | 0% | Mar 2024 |
|
| Susquehanna International | 152k | $259k | -78% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 142k | $241k | 0% | Mar 2024 |
|
| UBS Group | 134k | $227k | 5% | Mar 2024 |
|
| Marshall Wace | 132k | $224k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 119k | $203k | -97% | Mar 2024 |
|
| Bank of New York Mellon | 117k | $199k | -7% | Mar 2024 |
|
| AQR Capital Management | 115k | $196k | -27% | Mar 2024 |
|
| Man Group | 114k | $195k | 100% | Mar 2024 |
|
| Fishman Jay A | 80k | $136k | 167% | Mar 2024 |
|
| Bridgeway Capital Management | 75k | $128k | -21% | Mar 2024 |
|
| Assenagon Asset Management | 71k | $120k | 0% | Mar 2024 |
|
| Marquette Asset Management | 64k | $109k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 63k | $107k | 5% | Mar 2024 |
|
| State of Wyoming | 58k | $99k | 246% | Mar 2024 |
|
| UBS O'Connor | 57k | $97k | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 51k | $86k | 1% | Mar 2024 |
|
| Alliancebernstein | 51k | $157k | -6% | Dec 2023 |
|
| American Century Companies | 50k | $85k | 74% | Mar 2024 |
|
| Ameriprise Financial | 50k | $85k | -39% | Mar 2024 |
|
| T. Rowe Price Associates | 43k | $73k | 72% | Mar 2024 |
|
| GSA Capital Partners | 40k | $67k | 100% | Mar 2024 |
|
| Hsbc Holdings | 39k | $118k | 27% | Dec 2023 |
|
| Algert Coldiron Investors | 32k | $100k | 16% | Dec 2023 |
|
| Springbok Capital Management | 31k | $53k | 100% | Mar 2024 |
|
| Jane Street | 28k | $48k | 3% | Mar 2024 |
|
| Amundi | 26k | $42k | 0% | Mar 2024 |
|
| HighTower Advisors | 25k | $42k | 0% | Mar 2024 |
|
| Ohio Pers | 23k | $39k | 174% | Mar 2024 |
|
| American International | 19k | $59k | 0% | Dec 2023 |
|
| PanAgora Asset Management | 19k | $32k | 100% | Mar 2024 |
|
| Group One Trading | 16k | $27k | 34% | Mar 2024 |
|
| Mirae Asset Global Investments | 16k | $75k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 15k | $25k | 22% | Mar 2024 |
|
| Principal Financial Group | 14k | $24k | -9% | Mar 2024 |
|
| Ing Investment Management | 14k | $24k | -17% | Mar 2024 |
|
| Independent Advisor Alliance | 13k | $21k | 0% | Mar 2024 |
|
| Belvedere Trading | 11k | $19k | -69% | Mar 2024 |
|
| Cubist Systematic Strategies | 10k | $18k | -27% | Mar 2024 |
|
| Simplex Trading | 10k | $17k | 107% | Mar 2024 |
|
| New York State Common Retirement Fund | 10k | $17k | -1% | Mar 2024 |
|
| CI Private Wealth | 10k | $17k | 0% | Mar 2024 |
|
| ADAR1 Capital Management | 10k | $17k | 100% | Mar 2024 |
|
| Quantbot Technologies | 5.3k | $9.1k | 19% | Mar 2024 |
|
| Tower Research Capital | 4.6k | $7.9k | 117% | Mar 2024 |
|
| California State Teachers Retirement System | 4.1k | $7.0k | -52% | Mar 2024 |
|
| Summit Investment Advisors | 3.8k | $6.4k | 0% | Mar 2024 |
|
| Legal & General Group | 3.5k | $5.9k | 0% | Mar 2024 |
|
| Cutler | 2.6k | $4.2k | -50% | Mar 2024 |
|
| FMR | 2.5k | $4.3k | -18% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.6k | $2.7k | 0% | Mar 2024 |
|
| Amalgamated Bank | 1.3k | $2.0k | -63% | Mar 2024 |
|
| Royal Bank of Canada | 948.00 | $0 | -92% | Mar 2024 |
|
| Private Wealth Management Group | 676.00 | $1.2k | 0% | Mar 2024 |
|
| Efficient Wealth Management | 299.00 | $1.0k | 100% | Mar 2024 |
|
| CWM | 165.00 | $0 | 100% | Mar 2024 |
|
| Pnc Financial Services | 26.00 | $43.999800 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 8.00 | $13.000000 | 100% | Mar 2024 |
|
Who sold out of Pmv Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| venBio Select Advisor | Sep 2023 | 3.0M | $18M |
| Woodline Partners | Sep 2023 | 1.1M | $6.7M |
| Vontobel Holding | Dec 2023 | 686k | $2.1M |
| Wellington Management Company | Sep 2023 | 543k | $3.3M |
| Moore Capital Management | Dec 2023 | 104k | $322k |
| New York Life Investment Management | Dec 2023 | 73k | $225k |
| Trexquant Investment | Sep 2023 | 68k | $419k |
| Qube Research & Technologies | Sep 2023 | 64k | $393k |
| ExodusPoint Capital Management | Sep 2023 | 38k | $235k |
| Denali Advisors | Dec 2023 | 34k | $105k |
| Martingale Asset Management | Sep 2023 | 29k | $180k |
| Graham Capital Management | Dec 2023 | 23k | $71k |
| MetLife Investment Advisors | Sep 2023 | 22k | $136k |
| SG Americas Securities | Dec 2023 | 21k | $65k |
| Virtu Financial | Dec 2023 | 15k | $48k |
| Caption Management | Dec 2023 | 11k | $35k |
| Florida State Board of Administration | Dec 2023 | 11k | $35k |
| Metropolitan Life Insurance Company | Sep 2023 | 2.2k | $13k |
| Goss Wealth Management | Sep 2023 | 31.00 | $189.999000 |
| Advisor Group Holdings | Dec 2023 | 15.00 | $91.999500 |